               SEQUENCE LISTING

<110> Boehringer Ingelheim International GmbH

<120> NOVEL PROTEOLYSIS TARGETING CHIMERA (PROTACS) AND DERIVATIVES AS DEGRADERS OF SMARCA2 AND/OR SMARCA4

<130> 12-0434-WO-1

<150> PCT/EP2019/077830
<151> 2019-10-14
<150> EP18200596.7
<151> 2018-10-16

<160> 1

<170> BiSSAP 1.3.6

<210> 1
<211> 125
<212> PRT
<213> Artificial Sequence


<220> 
<223> ElonginB followed by a short spacer and AviTag Sequence at the
      C-terminus

<400> 1
Met Asp Val Phe Leu Met Ile Arg Arg His Lys Thr Thr Ile Phe Thr 
1               5                   10                  15      
Asp Ala Lys Glu Ser Ser Thr Val Phe Glu Leu Lys Arg Ile Val Glu 
            20                  25                  30          
Gly Ile Leu Lys Arg Pro Pro Asp Glu Gln Arg Leu Tyr Lys Asp Asp 
        35                  40                  45              
Gln Leu Leu Asp Asp Gly Lys Thr Leu Gly Glu Cys Gly Phe Thr Ser 
    50                  55                  60                  
Gln Thr Ala Arg Pro Gln Ala Pro Ala Thr Val Gly Leu Ala Phe Arg 
65                  70                  75                  80  
Ala Asp Asp Thr Phe Glu Ala Leu Cys Ile Glu Pro Phe Ser Ser Pro 
                85                  90                  95      
Pro Glu Leu Pro Asp Val Met Lys Gly Ser Pro Ala Gly Gly Gly Leu 
            100                 105                 110         
Asn Asp Ile Phe Glu Ala Gln Lys Ile Glu Trp His Glu 
        115                 120                 125 

